“TLR7/8 agonist MEDI9197”的概念、定义、翻译、参考文献-科学参考

A toll-like receptor type 7 and 8 (TLR7/8) agonist with potential immunostimulating and antitumor activities. Upon intratumoral administration, TLR7/8 agonist MEDI9197 binds to and activates TLR7 and 8, thereby stimulating antigen-presenting cells (APCs), including dendritic cells (DCs). Activation of DCs results in the production of proinflammatory cytokines, and the activation of cytotoxic T-lymphocyte (CTL) and B-lymphocyte immune responses. This may cause tumor cell lysis. TLR7 and 8, members of the TLR family, play fundamental roles in the activation of the immune system. Check for active clinical trialsusing this agent.

单词	TLR7/8 agonist MEDI9197
释义	TLR7/8 agonist MEDI9197 A toll-like receptor type 7 and 8 (TLR7/8) agonist with potential immunostimulating and antitumor activities. Upon intratumoral administration, TLR7/8 agonist MEDI9197 binds to and activates TLR7 and 8, thereby stimulating antigen-presenting cells (APCs), including dendritic cells (DCs). Activation of DCs results in the production of proinflammatory cytokines, and the activation of cytotoxic T-lymphocyte (CTL) and B-lymphocyte immune responses. This may cause tumor cell lysis. TLR7 and 8, members of the TLR family, play fundamental roles in the activation of the immune system. Check for active clinical trialsusing this agent.
随便看	methyl group methylmercaptopurine riboside methylnaltrexone methylnaltrexone methylnaltrexone bromide methylphenidate hydrochloride methylprednisolone Meti-derm metoclopramide metoclopramide hydrochloride metoprine metoprolol MET receptor tyrosine kinase inhibitor SGX523 Metrocort Metro I.V. metronidazole metronidazole hydrochloride metronomic therapy Met tyrosine kinase inhibitor BMS-777607 MET tyrosine kinase inhibitor EMD 1204831 MET tyrosine kinase inhibitor EMD 1214063 MET tyrosine kinase inhibitor PF-02341066 MET tyrosine kinase inhibitor PF-04217903 MET tyrosine kinase inhibitor SAR125844 MET/VEGFR-2 inhibitor GSK1363089